Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (8551)	5/31/2003 8:59:28 AM
From: Icebrg	Read Replies (1) \| Respond to of 52153

Peter >>In any event, the abstracts are often out of date, and the "live" updates on the day of the actual presentations would still be newsworthy.>> Yes, that should be the case. One attendee noted: "Today there were only industry sponsored educational sessions. But we did get the abstract books with study results at the time of abstract submission." The deadline for submission of abstracts to the current conference was Dec 20, 2002. I have a feeling that the preliminary ones often serve as no more than "place-holders" for the real thing. For cancer clinical trials half a year can make a quite a big difference, both as far as survival is concerned as well as for the numbers of evaluated patients. Erik